
New and promising GSM treatments, more clinical takeaways from NAMS 2018
Oct 17, 2018 - 22:19
Radio and PodcastLive Radio & Podcasts
How does Dr. Stuenkel recommend the problem of increased compounded hormone therapy use be addressed?
What to do about the problem of non-FDA approved compounded bioidentical hormones is an episode from OBGcast by Tyler Mundhenk. How does Dr. Stuenkel recommend the problem of increased compounded hormone therapy use be addressed? The episod...
This episode belongs to OBGcast.
Use the player on this page to stream the episode online.
Published Aug 20, 2018, 09:40 long, audio available.
How does Dr. Stuenkel recommend the problem of increased compounded hormone therapy use be addressed?
You can listen to What to do about the problem of non-FDA approved compounded bioidentical hormones online on Radio and Podcast. Open the player on this page to stream the available audio.
What to do about the problem of non-FDA approved compounded bioidentical hormones is an episode from OBGcast by Tyler Mundhenk.
This episode is 09:40 long.
This episode was published on Aug 20, 2018.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from OBGcast when more episodes are available from the podcast feed.
You can listen to What to do about the problem of non-FDA approved compounded bioidentical hormones on this page when the episode audio is available from the podcast feed.
What to do about the problem of non-FDA approved compounded bioidentical hormones is from OBGcast by Tyler Mundhenk.
Published Aug 20, 2018 and 09:40 long